Cited by 684Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Open access

Martin, Lee J., Pan, Yan, Price, Ann C., Sterling, Wanda, Copeland, Neal G., Jenkins, Nancy A., Price, Donald L., Lee, Michael K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.4308-05.2006PMC PMC6381830

Open this paper in CoChat — free account Open PDF

Abstract

α-Synuclein (α-Syn) is enriched in nerve terminals. Two mutations in the α-Syn gene (Ala53→ Thr and Ala30→ Pro) occur in autosomal dominant familial Parkinson's disease. Mice overexpressing the human A53T mutant α-Syn develop a severe movement disorder, paralysis, and synucleinopathy, but the mechanisms are not understood. We examined whether transgenic mice expressing human wild-type or familial Parkinson's disease-linked A53T or A30P mutant α-syn develop neuronal degeneration and cell death. Mutant mice were examined at early- to mid-stage disease and at near end-stage disease. Age-matched nontransgenic littermates were controls. In A53T mice, neurons in brainstem and spinal cord exhibited large axonal swellings, somal chromatolytic changes, and nuclear condensation. Spheroid eosinophilic Lewy body-like inclusions were present in the cytoplasm of cortical neurons and spinal motor neurons. These inclusions contained human α-syn and nitrated synuclein. Motor neurons were depleted (∼75%) in A53T mice but were affected less in A30P mice. Axonal degeneration was present in many regions. Electron microscopy confirmed the cell and axonal degeneration and revealed cytoplasmic inclusions in dendrites and axons. Some inclusions were degenerating mitochondria and were positive for humanα-syn. Mitochondrial complex IV and V proteins were at control levels, but complex IV activity was reduced significantly in spinal cord. Subsets of neurons in neocortex, brainstem, and spinal cord ventral horn were positive for terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling, cleaved caspase-3, and p53. Mitochondria in neurons had terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling-positive matrices and p53 at the outer membrane. Thus, A53T mutant mice develop intraneuronal inclusions, mitochondrial DNA damage and degeneration, and apoptotic-like death of neocortical, brainstem, and motor neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4308-05.2006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“p53 can mediate mitochondrial membrane permeabilization and apoptosis by activating Bax and Bak (Chipuk et al., 2004; Leu et al., 2004).”
Background
Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders
Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,779
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,567
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,428

Show all 59 references

Research works printed but not linked: 6

Chayen J, Bitensky L, Butcher R (1973) Practical histochemistry. New York: Wiley.
2001, Int J Mol Med, 7, 455
2002, J Neurobiol, 5, 181
2002, Neurochem Res, 27, 1089
1997, J Comp Neurol, 378, 70
2000, J Biol Chem, 265, 18344

Sorted by citations

Items 201–300 of 684

The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats
Samantaray, S., Knaryan, V. H., Guyton, M. K., Matzelle, D. D., Ray, S. K., & Banik, N. L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.056 · Cited by 95
Oligomeric α-synuclein inhibits tubulin polymerization
Chen, L., Jin, J., Davis, J., Zhou, Y. F., Wang, Y., Liu, J., Lockhart, P. J., & Zhang, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.163 · Cited by 94
Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Trancikova, A. K., Tsika, E., & Moore, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4200 · Cited by 94
Interaction of α-synuclein with biomembranes in Parkinson's disease —role of cardiolipin
Ghio, S., Kamp, F., Cauchi, R. J., Giese, A., & Vassallo, N. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.005 · Cited by 95
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
Pellegrini, C., D’Antongiovanni, V., Miraglia, F., Rota, L., Benvenuti, L., Salvo, C. D., Testa, G., Capsoni, S., Carta, G., Antonioli, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00263-x · Cited by 96
The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches
Drobny, A., Huarcaya, S. P., Dobert, J. P., Kluge, A., Bunk, J., Schlothauer, T., & Zunke, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119243 · Cited by 94
Mitochondrial Dysfunction and α -Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
Zaltieri, M., Longhena, F., Pizzi, M., Missale, C., Spano, P., & Bellucci, A. (2015) · Parkinson s Disease · doi:10.1155/2015/108029 · Cited by 95
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
Esteves, A. R., Arduíno, D. M., Silva, D. F., Oliveira, C. R., & Cardoso, S. M. (2011) · Parkinson s Disease · doi:10.4061/2011/693761 · Cited by 90
Synaptic Activity and Bioenergy Homeostasis: Implications in Brain Trauma and Neurodegenerative Diseases
Khatri, N., & Man, H. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00199 · Cited by 96
The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases
Redmann, M., Darley-Usmar, V. M., & Zhang, J. (2016) · Aging and Disease · doi:10.14336/ad.2015.0820 · Cited by 93
Synphilin-1 attenuates neuronal degeneration in the A53T -synuclein transgenic mouse model
Smith, W. W., Liu, Z. W., Liang, Y., Masuda, N., Swing, D. A., Jenkins, N. A., Copeland, N. G., Troncoso, J. C., Pletnikov, M. V., Dawson, T. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq086 · Cited by 94
Self-citation
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Qureshi, H. Y., & Paudel, H. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178905 · Cited by 90
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A. M. A., Mladenović, A., Lopez-Contreras, A. J., Henriques, C. M., Selman, C., Ferreiro, E. B., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 92
Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria
Schmidt, S., Linnartz‐Gerlach, B., Mendritzki, S., Sczepan, T., Lübbert, M., Stichel, C. C., & Lübbert, H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq564 · Cited by 93
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
O’Hara, D. M., Pawar, G. N., Kalia, S. K., & Kalia, L. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00577 · Cited by 89
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130216 · Cited by 89
Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease
Varçin, M., Bentea, E., Michotte, Y. M., & Sarre, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/624925 · Cited by 86
Mitochondrial quality control and neurological disease: an emerging connection
de Castro, I. P., Martins, L. M., & Tufi, R. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001456 · Cited by 92
Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Mitochondrial lipids in neurodegeneration
Aufschnaiter, A., Kohler, V., Diessl, J., Peselj, C., Carmona‐Gutiérrez, D., Keller, W., & Büttner, S. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2463-1 · Cited by 91
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
Rota, L., Pellegrini, C., Benvenuti, L., Antonioli, L., Fornai, M., Blandizzi, C., Cattaneo, A., & Colla, E. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0146-z · Cited by 87
Mitochondria and Energetic Depression in Cell Pathophysiology
Seppet, E. K., Puurand, M., Peetsalu, A., Gizatullina, Z. Z., Nguyen, H. P., Vielhaber, S., Wussling, M. H. P., Trumbeckaitė, S., Arandarčikaitė, O., Jerzembek, D., et al. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10052252 · Cited by 84
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Autophagy, lithium, and amyotrophic lateral sclerosis
Pasquali, L., Longone, P., Isidoro, C., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2009) · Muscle & Nerve · doi:10.1002/mus.21423 · Cited by 84
Mitochondriopathy in Parkinson Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248541.05552.c4 · Cited by 83
Self-citation
Brain Mitochondria, Aging, and Parkinson’s Disease
Rango, M., & Bresolin, N. (2018) · Genes · doi:10.3390/genes9050250 · Cited by 87
Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons
Chavarría, C., Rodríguez-Bottero, S., Quijano, C., Cassina, P., & Souza, J. M. (2018) · Biochemical Journal · doi:10.1042/bcj20180297 · Cited by 83
Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research
Lama, J., Buhidma, Y., Fletcher, E. J. R., & Duty, S. (2021) · Neuronal Signaling · doi:10.1042/ns20210026 · Cited by 93
Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
Bourdenx, M., Bézard, E., & Dehay, B. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00083 · Cited by 88
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
Mounsey, R. B., & Teismann, P. (2010) · Parkinson s Disease · doi:10.4061/2011/617472 · Cited by 86
Mitochondrial Pathology in Parkinson's Disease
Schapira, A. H. V. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20303 · Cited by 83
Cell Death Pathways in Parkinson's Disease: Role of Mitochondria
Yao, Z., & Wood, N. W. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2624 · Cited by 80
Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson’s disease
Todd, A. M., & Staveley, B. E. (2008) · Genome · doi:10.1139/g08-085 · Cited by 83
Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system
Noorian, A. R., Rha, J., Annerino, D. M., Bernhard, D., Taylor, G. M., & Greene, J. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.005 · Cited by 80
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice
Sekar, S., Ranju, V., Kalaivani, P., Priya, R. J., Sumathy, H., Sunil, A. G., & Chidambaram, S. B. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.025 · Cited by 78
Parkinson’s disease mouse models in translational research
Antony, P. M. A., Diederich, N. J., & Balling, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9330-x · Cited by 84
New insights into mitochondrial structure during cell death
Perkins, G. A., Bossy‐Wetzel, E., & Ellisman, M. H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.021 · Cited by 79
Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells
Bussi, C., Ramos, J. M. P., Arroyo, D. S., Gallea, J. I., Ronchi, P., Kolovou, A., Wang, J. M., Florey, O., Celej, M. S., Schwab, Y., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.226241 · Cited by 76
Mechanisms of alpha-synuclein toxicity: An update and outlook
Brás, I. C., Xylaki, M., & Outeiro, T. F. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 78
Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease
Chu, Y., Goldman, J. G., Kelly, L. P., He, Y., Waliczek, T., & Kordower, J. H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.003 · Cited by 71
Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity
O’Donnell, K. C., Lulla, A., Stahl, M. C., Wheat, N. D., Bronstein, J. M., & Sagasti, A. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013185 · Cited by 75
Intracellular Dynamics of Synucleins
Surguchov, A. P. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.07.007 · Cited by 77
Parkinson’s disease: a rethink of rodent models
Melrose, H. L., Lincoln, S. J., Tyndall, G. M., & Farrer, M. J. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0461-3 · Cited by 74
Subcellular localization of alpha-synuclein aggregates and their interaction with membranes
Colla, E., Miraglia, F., Ricci, A., & Rota, L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235013 · Cited by 78
Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?
da Costa, C. A., & Checler, F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.020 · Cited by 75
SUMO ‐regulated mitochondrial function in Parkinson's disease
Souza, A. C. G., Prediger, R. D., & Cimarosti, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13599 · Cited by 78
Parkinson’s Disease: The Mitochondria-Iron Link
Muñoz, Y., Carrasco, C. M., Campos, J., Aguirre, P., & Núñez, M. T. (2016) · Parkinson s Disease · doi:10.1155/2016/7049108 · Cited by 76
Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration
Song, S., Jiang, L., Oyarzabal, E. A., Wilson, B. C., Li, Z., Shih, Y. I., Wang, Q., & Hong, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1235-1 · Cited by 74
Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders
Reddy, A. P., Ravichandran, J., & Carkaci‐Salli, N. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.020 · Cited by 71
The role of lipids in α-synuclein misfolding and neurotoxicity
Ugalde, C. L., Lawson, V., Finkelstein, D. I., & Hill, A. F. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007500 · Cited by 77
The relationship of alpha-synuclein to mitochondrial dynamics and quality control
Thorne, N. J., & Tumbarello, D. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.947191 · Cited by 78
Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization
Lee, Y., Park, H. R., Chun, H. J., & Lee, J. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23544 · Cited by 73
MicroRNA and proteome expression profiling in early‐symptomatic α‐synuclein(A30P)‐transgenic mice
Gillardon, F., Mack, M., Rist, W., Schnack, C., Lenter, M., Hildebrandt, T., & Hengerer, B. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780025 · Cited by 73
α-Synuclein amino terminus regulates mitochondrial membrane permeability
Shen, J., Du, T., Wang, X., Duan, C., Gao, G., Zhang, J., Lu, L., & Yang, H. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.046 · Cited by 72
Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates
Yasuda, T., Miyachi, S., Kitagawa, R., Wada, K., Nihira, T., Ren, Y., Hirai, Y., Ageyama, N., Terao, K., Shimada, T., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.052 · Cited by 72
C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
Wang, H., Chen, G., Ahn, E. H., Xia, Y., Kang, S. S., Liu, X., Liu, C., Han, M.-H., Chen, S., & Ye, K. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-022-00430-8 · Cited by 71
Genetically engineered mouse models of Parkinson's disease
Crabtree, D., & Zhang, J. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.019 · Cited by 73
Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: Insights from a transgenic mouse model
Willison, L. D., Kudo, T., Loh, D. H., Kuljis, D. A., & Colwell, C. S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.014 · Cited by 73
Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment
Martínez, J. H., Fuentes, F., Vanasco, V., Álvarez, S., Alaimo, A., Cassina, A., Leskow, F. C., & Velazquez, F. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.04.018 · Cited by 78
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 74
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Lei, Q., Wu, T., Wu, J., Hu, X., Guan, Y., Wang, Y., Yan, J., & Shi, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12374 · Cited by 74
α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability
Feng, L., Federoff, H. J., Vicini, S., & Maguire‐Zeiss, K. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07266.x · Cited by 72
Succinate dehydrogenase: Prospect for neurodegenerative diseases
Farshbaf, M. J., & Kiani‐Esfahani, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.12.002 · Cited by 71
Mitophagy and Its Contribution to Metabolic and Aging-Associated Disorders
Liu, L., Liao, X., Wu, H., Li, Y., Zhu, Y., & Chen, Q. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8013 · Cited by 69
Parkinson’s Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes
Robea, M. A., Balmuș, I.-M., Ciobica, A. S., Strungaru, Ș.-A., Plavan, G. I., Gorgan, L., Săvucă, A., & Nicoară, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1370837 · Cited by 68
Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
Luna, E., & Luk, K. C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.023 · Cited by 67
α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles
Varkey, J., Mizuno, N., Hegde, B. G., Cheng, N., Steven, A. C., & Langen, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476697 · Cited by 71
Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons
Caudal, D., Alvarsson, A., Björklund, A., & Svenningsson, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.09.002 · Cited by 73
α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment
Karim, M. R., Liao, E. E., Kim, J., Meints, J. P., Martínez, H., Pletniková, O., Troncoso, J. C., & Lee, M. K. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00364-w · Cited by 66
Self-citation
Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_356 · Cited by 65
Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
González-Hernández, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00140 · Cited by 65
Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease
Greene, J. G. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5859 · Cited by 69
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Ottolini, D., Calí, T., Szabó, I., & Brini, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0201 · Cited by 65
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Ryu, T., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add0499 · Cited by 64
Mitochondrial dysfunction and Parkinson’s disease genes: insights from Drosophila
Park, J., Kim, Y., & Chung, J. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003178 · Cited by 64
New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease
Xie, W., Wan, O. W., & Chung, K. K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.014 · Cited by 66
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease
Bej, E., Cesare, P., Volpe, A. R., d’Angelo, M., & Castelli, V. (2024) · Neurology International · doi:10.3390/neurolint16030037 · Cited by 74
Mitochondrial therapies for Parkinson's disease
Thomas, B., & Beal, M. F. (2010) · Movement Disorders · doi:10.1002/mds.22781 · Cited by 62
Caloric restriction and the precision-control of autophagy: A strategy for delaying neurodegenerative disease progression
Ntsapi, C., & Loos, B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.07.014 · Cited by 65
Transgenic Mice with Human Mutant Genes Causing Parkinson's Disease and Amyotrophic Lateral Sclerosis Provide Common Insight into Mechanisms of Motor Neuron Selective Vulnerability to Degeneration
Martin, L. J. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.115 · Cited by 61
Self-citation
Inhibition of lysosomal functions reduces proteasomal activity
Qiao, L., & Zhang, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.085 · Cited by 61
MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian
Mo, M., Xiao, Y., Huang, S., Cen, L., Chen, X. '., Zhang, L., Luo, Q., Li, S., Yang, X., Lin, X. Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13905 · Cited by 62
Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach
George, G., Singh, S., Lokappa, S. B., & Varkey, J. (2018) · Genomics · doi:10.1016/j.ygeno.2018.05.005 · Cited by 58
Parkinson's disease‐associated protein Parkin: an unusual player in cancer
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0314-z · Cited by 61
Cross-talk between mitochondria and proteasome in Parkinson’s disease pathogenesis
Martins-Branco, D. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00017 · Cited by 63
Molecular insights into Parkinson's disease
Thomas, B., & Beal, M. F. (2011) · F1000 Medicine Reports · doi:10.3410/m3-7 · Cited by 62
AMPK in Neurodegenerative Diseases
Domise, M., & Vingtdeux, V. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_7 · Cited by 61
Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Coleman, C., & Martin, I. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223363 · Cited by 65
Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease
Schneider, L. E., & Zhang, J. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-14 · Cited by 59
Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions
Anandhan, A., Lei, S., Levytskyy, R. M., Pappa, A., Panayiotidis, M. I., Cerny, R. L., Khalimonchuk, O., Powers, R., & Franco, R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9906-2 · Cited by 60
Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration
Wang, Q., Oyarzabal, E. A., Song, S., Wilson, B. C., Santos, J. H., & Hong, J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.003 · Cited by 59
Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human α-Synuclein
Zhou, W., Milder, J. B., & Freed, C. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710232200 · Cited by 57
Chemically Induced Models of Parkinson’s Disease: History and Perspectives for the Involvement of Ferroptosis
Wen, S., Aki, T., Unuma, K., & Uemura, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581191 · Cited by 61
Model fusion: The next phase in developing animal models for parkinson’s disease
Manning-Bog, A., & Langston, J. W. (2007) · Neurotoxicity Research · doi:10.1007/bf03033569 · Cited by 56
YGR198w (YPP1) targets A30P α-synuclein to the vacuole for degradation
Flower, T. R., Clark-Dixon, C., Metoyer, C. F., Yang, H., Shi, R., Zhang, Z., & Witt, S. N. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610071 · Cited by 56
Mitochondrial dynamics and neuronal fate in Parkinson's disease
Santos, D., & Cardoso, S. M. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.05.002 · Cited by 60
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Ganguly, U., Chakrabarti, S. S., Kaur, U., Mukherjee, A., & Chakrabarti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171129100944 · Cited by 58
Ammon’s Horn 2 (CA2) of the Hippocampus: A Long-Known Region with a New Potential Role in Neurodegeneration
Pang, C. C.-C., Kiecker, C. M., O'Brien, J. T., Noble, W. J., & Chang, R. C. (2018) · The Neuroscientist · doi:10.1177/1073858418778747 · Cited by 60
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC
Rovini, A. M. F., Gurnev, P. A., Beilina, A. G., Queralt-Martín, M., Rosencrans, W. M., Cookson, M., Bezrukov, S. M., & Rostovtseva, T. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03386-w · Cited by 56
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
Indrieri, A., Pizzarelli, R., Franco, B., & Leonibus, E. D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.567129 · Cited by 57

Authors: Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
ORCID: Martin, Lee J.
Jenkins, Nancy A.
Lee, Michael K.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-01-04
Volume: 26
Issue: 1
Pages: 41-50
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.4308-05.2006
PMC: PMC6381830
OpenAlex: W2084910880
Cited by: 684
References: 59
Citations by year: 2026: 15 · 2025: 14 · 2024: 24 · 2023: 27 · 2022: 37 · 2021: 34 · 2020: 27 · 2019: 34 · 2018: 39 · 2017: 43 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 41 · 2012: 49
FWCI: 26.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (NS38377)
U.S. Public Health Service
National Institute on Aging (AG 16282, R01AG016282)
National Institute of Neurological Disorders and Stroke (NS 38377, R01NS052098, NS34 100, P01NS038065, R56NS038065, P50NS038377, NS 38065, R01NS034100, R01NS038065, NS52098)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: alpha-synuclein, Parkinson's disease, A53T mutation, A30P mutation, transgenic mice, mitochondrial degeneration, neuronal cell death, motor neuron degeneration, axonal degeneration, Lewy bodies, mitochondrial DNA damage, apoptosis, caspase-3, p53, mitochondrial complex IV, synucleinopathies
MeSH terms: Alanine, Animals, Brain Stem, DNA Damage, Humans, Mice, Transgenic, Mitochondria, Mutation, Nerve Degeneration, Parkinson Disease, Threonine, Cell Death, Neocortex, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks